» Authors » Nirzari Gupta

Nirzari Gupta

Explore the profile of Nirzari Gupta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 111
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kirkpatrick D, Gupta N, Gopalaswamy R, Kolhatkar R, Hudson-Davis M, Keire D
AAPS J . 2025 Mar; 27(2):61. PMID: 40087229
Enabling greater flexibility for lifecycle management of analytical procedures is one of the primary features of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)...
2.
Stafford M, Dunn R, Gupta N, Kakarla R, Kirkpatrick D, Magparangalan D, et al.
AAPS J . 2023 Dec; 26(1):7. PMID: 38114792
The FDA initiated a cross-sectional, statistically based sampling and testing study to characterize the quality of marketed alcohol-based hand sanitizer (ABHS) by evaluating the alcohol content and impurities present in...
3.
Hatipoglu M, Zaker Y, Willett D, Gupta N, Rodriguez J, Patankar S, et al.
Anal Chem . 2023 Oct; 95(41):15325-15332. PMID: 37796650
Two decades ago, postmarket discovery of a second crystal form of ritonavir with lower solubility had major implications for drug manufacturers and patients. Since then, ritonavir has been reformulated via...
4.
Gupta N, Rodriguez J, Yilmaz H
Commun Chem . 2023 Jan; 4(1):126. PMID: 36697655
The COVID-19 pandemic created an increased demand for hygiene supplies such as hand sanitizers. In response, a large number of new domestic or imported hand sanitizer products entered the US...
5.
Agarwal S, Behring M, Kim H, Bajpai P, Chakravarthi B, Gupta N, et al.
Transl Oncol . 2021 Sep; 14(11):101142. PMID: 34538338
No abstract available.
6.
Agarwal S, Behring M, Kim H, Chandrashekar D, Chakravarthi B, Gupta N, et al.
Mol Oncol . 2020 Oct; 14(12):3007-3029. PMID: 33037736
Overexpression of TRIP13, a member of the AAA-ATPase family, is linked with various cancers, but its role in metastasis is unknown in colorectal cancer (CRC). In the current study, we...
7.
Agarwal S, Chakravarthi B, Kim H, Gupta N, Hale K, Balasubramanya S, et al.
Transl Oncol . 2020 May; 13(7):100776. PMID: 32422575
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with an extremely poor prognosis. There is an urgent need to identify new therapeutic targets and also understand the mechanism of PDAC...
8.
Agarwal S, Chakravarthi B, Behring M, Kim H, Chandrashekar D, Gupta N, et al.
Cancers (Basel) . 2020 Mar; 12(4). PMID: 32218208
The identification of colorectal cancer (CRC) molecular targets is needed for the development of drugs that improve patient survival. We investigated the functional role of phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase...
9.
Agarwal S, Behring M, Kim H, Bajpai P, Chakravarthi B, Gupta N, et al.
Transl Oncol . 2020 Mar; 13(4):100754. PMID: 32199274
Deposition, remodeling, and signaling of the extracellular matrix facilitate tumor growth and metastasis. Here, we demonstrated that an enzyme, collagen prolyl 4-hydroxylase, alpha polypeptide I (P4HA1), which is involved in...
10.
Gupta N, Kozlovskaya V, Dolmat M, Kharlampieva E
Langmuir . 2019 Jul; 35(33):10910-10919. PMID: 31356750
The mechanical properties of microparticles intended for in vivo applications as drug delivery vehicles are among important parameters that influence their circulation in the blood and govern particle biodistribution. We...